Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan

被引：0
|
作者：
Geetha, Duvuru [1 ]
Cortazar, Frank [2 ]
Karras, Alexandre [3 ]
Bruchfeld, Annette [4 ]
Yue, Huibin [5 ]
Merkel, Peter [6 ]
Jayne, David [7 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] New York Nephrol, Watervliet, NY USA
[3] HEGP APHP, Paris, France
[4] Karolinska Inst, Stockholm, Sweden
[5] Amgen Inc, Thousand Oaks, CA USA
[6] Univ Penn, Philadelphia, PA USA
[7] Univ Cambridge, Cambridge, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0857
引用
收藏
页码：1719 / 1721
页数：3
相关论文
共 50 条
  • [41] Severe infections in patients with ANCA-associated vasculitis treated with rituximab
    Segelmark, Leo
    Flores-Suarez, Luis
    Mohammad, Aladdin
    RHEUMATOLOGY, 2022, 61 (01) : 205 - 212
  • [42] Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1366 - 1367
  • [43] Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
    van Leeuwen, Jolijn R.
    Quartuccio, Luca
    Draibe, Juliana Bordignon
    Gunnarson, Iva
    Sprangers, Ben
    Teng, Y. K. Onno
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19
  • [44] Avacopan for the Treatment of ANCA-associated Vasculitis. Real World Experience in Spain
    Espigol-Frigole, Georgina
    Cid, Maria C.
    Bordignon Draibe, Juliana
    Carmen Prados, Maria
    Guillen, Elena
    Huerta, Ana
    Villacorta, Javier
    Vega, Cristina
    Martins, Judith
    Gracia, Borja
    Morales, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1369 - 1370
  • [45] Avacopan for the Treatment of ANCA-Associated Vasculitis (vol 384, pg 599, 2021)
    Jayne, David R. W.
    Merkel, Peter A.
    Schall, Thomas J.
    Bekker, Pirow
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 388 - 388
  • [46] Early Experience with Avacopan for ANCA-Associated Vasculitis in a Large Integrated Healthcare System
    Srivatsan, Shruthi
    Williams, Zachary
    Cook, Claire
    Fu, Xiaoqing
    Patel, Naomi
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1711 - 1712
  • [47] Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
    van Leeuwen, Jolijn R.
    Teng, Yoe Kie Onno
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 499 - 500
  • [48] ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH SLE
    Ziauddin, O.
    Levine, J.
    Cedillo-Couvert, E.
    Setty, S.
    Arami, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (04) : 873 - 874
  • [49] Morbidity in patients with ANCA-associated vasculitis
    Harper, Lorraine
    PRESSE MEDICALE, 2013, 42 (04): : 612 - 616
  • [50] ANCA-Associated Vasculitis Treated with Avacopan versus a Standard Prednisone Taper: Glucocorticoid Toxicity Index Scores by Domain
    Patel, Naomi
    Jayne, David
    Merkel, Peter
    Bekker, Pirow
    Zhang, Yuqing
    Yue, Huibin
    Stone, John
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2141 - 2142
12345